Open AccessAbstract 1836: Patient-derived xenograft (PDX) models expressing HER2 reflect clinical responses to targeted HER2 inhibition
Author(s) -
Daniel Ciznadija,
Amir Sonnenblick,
Jennifer Jaskowiak,
Angela M. Davies,
David Sidransky
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-1836
Subject(s) - lapatinib , trastuzumab , medicine , oncology , immunohistochemistry , breast cancer , cancer , pertuzumab , cancer research